• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈上皮内瘤变治疗后宫颈阴道微生物组。系统评价和荟萃分析方案。

Cervicovaginal Microbiome after Cervical Intraepithelial Neoplasia Treatment. A Protocol for Systematic Review and Meta-Analysis.

机构信息

Saint Sophia Hospital, Żelazna 90 Street, 01-004 Warsaw, Poland.

Department of Basic Biomedical Science, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, Kasztanowa 3 Street, 41-200 Sosnowiec, Poland.

出版信息

Int J Environ Res Public Health. 2021 Aug 27;18(17):9050. doi: 10.3390/ijerph18179050.

DOI:10.3390/ijerph18179050
PMID:34501639
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8431715/
Abstract

(1) Background: The microbiome consists of microorganisms from various kingdoms with numerous physical and chemical properties Lactobacillus species constitute the highest percentage of healthy cervical and vaginal microbiota. Dysbiosis may cause adverse outcomes, e.g., bacterial vaginosis, pelvic inflammatory disease and pregnancy complications. The cervicovaginal microbiome might contribute to the development of a persistent HPV infection-the main risk factor of cervical cancer-and influence progression to malignancy The aim is to perform a systematic review of current literature and a meta-analysis regarding microbiome changes after cervical intraepithelial neoplasia treatment. (2) Methods: We will search PubMed, Scopus, Google Scholar and Embase Database and trace citations in the reference sections. Randomized and non-randomized controlled studies, case-control and cohort studies published between January 2000 and May 2021 will be included in the study protocol. The following keywords will be used: 'microbiome', 'vaginal microbiome', 'cervical microbiome', 'cervical neoplasia treatment', 'conization', 'electroconization', and 'electrosurgical treatment'. Statistical analyses will be performed using RevMan 5.4. (3) Results: The results will be published as a peer-reviewed article. (4) Conclusions: The study will show which forms of intraepithelial neoplasia treatment change the cervicovaginal microbiome. Finding the best form of treatment by studying the cervicovaginal microbiome after various forms of treatment is essential. Patients would benefit not only from the treatment of the initial disease but also the management of dysbiosis, which might underlie other pathologies.

摘要

(1) 背景:微生物组由具有众多物理和化学特性的来自不同王国的微生物组成,其中乳杆菌属构成了健康宫颈和阴道微生物组的最高比例。微生态失调可能导致不良后果,例如细菌性阴道病、盆腔炎和妊娠并发症。宫颈阴道微生物组可能有助于持续性 HPV 感染的发展-宫颈癌的主要危险因素,并影响向恶性肿瘤的进展。目的是对目前关于宫颈上皮内瘤变治疗后微生物组变化的文献进行系统评价和荟萃分析。 (2) 方法:我们将搜索 PubMed、Scopus、Google Scholar 和 Embase 数据库,并追踪参考文献中的引文。将纳入本研究方案的研究类型包括:2000 年 1 月至 2021 年 5 月期间发表的随机和非随机对照研究、病例对照研究和队列研究。以下关键词将被使用:'微生物组'、'阴道微生物组'、'宫颈微生物组'、'宫颈肿瘤治疗'、'锥形切除术'、'电凝切除术'和'电外科治疗'。统计分析将使用 RevMan 5.4 进行。 (3) 结果:结果将作为同行评议文章发表。 (4) 结论:该研究将展示哪些形式的上皮内瘤变治疗会改变宫颈阴道微生物组。通过研究各种治疗形式后宫颈阴道微生物组,找到最佳的治疗形式至关重要。患者不仅将受益于初始疾病的治疗,还将受益于可能是其他病理基础的微生态失调的管理。

相似文献

1
Cervicovaginal Microbiome after Cervical Intraepithelial Neoplasia Treatment. A Protocol for Systematic Review and Meta-Analysis.宫颈上皮内瘤变治疗后宫颈阴道微生物组。系统评价和荟萃分析方案。
Int J Environ Res Public Health. 2021 Aug 27;18(17):9050. doi: 10.3390/ijerph18179050.
2
Cervicovaginal microbiome, high-risk HPV infection and cervical cancer: Mechanisms and therapeutic potential.宫颈阴道微生物组、高危型 HPV 感染与宫颈癌:机制与治疗潜力。
Microbiol Res. 2024 Oct;287:127857. doi: 10.1016/j.micres.2024.127857. Epub 2024 Jul 26.
3
Association of cervicovaginal dysbiosis mediated HPV infection with cervical intraepithelial neoplasia.宫颈阴道微生态失衡介导的 HPV 感染与宫颈上皮内瘤变的关系。
Microb Pathog. 2021 Mar;152:104780. doi: 10.1016/j.micpath.2021.104780. Epub 2021 Feb 3.
4
Safety, efficacy and immunogenicity of therapeutic vaccines in the treatment of patients with high-grade cervical intraepithelial neoplasia associated with human papillomavirus: a systematic review protocol.治疗性疫苗治疗人乳头瘤病毒相关高级别宫颈上皮内瘤变患者的安全性、有效性和免疫原性:一项系统评价方案
BMJ Open. 2019 Jul 17;9(7):e026975. doi: 10.1136/bmjopen-2018-026975.
5
Associations of Cervicovaginal Lactobacilli With High-Risk Human Papillomavirus Infection, Cervical Intraepithelial Neoplasia, and Cancer: A Systematic Review and Meta-Analysis.宫颈阴道乳杆菌与高危型人乳头瘤病毒感染、宫颈上皮内瘤变和宫颈癌的相关性:系统评价和荟萃分析。
J Infect Dis. 2019 Sep 13;220(8):1243-1254. doi: 10.1093/infdis/jiz325.
6
Cervical microbiota in women with cervical intra-epithelial neoplasia, prior to and after local excisional treatment, a Norwegian cohort study.挪威队列研究:宫颈上皮内瘤变女性在局部切除治疗前后的宫颈微生物群
BMC Womens Health. 2019 Feb 6;19(1):30. doi: 10.1186/s12905-019-0727-0.
7
The vaginal microbiota, human papillomavirus and cervical dysplasia: a systematic review and network meta-analysis.阴道微生物群、人乳头瘤病毒与宫颈发育不良:系统评价与网络荟萃分析。
BJOG. 2020 Jan;127(2):171-180. doi: 10.1111/1471-0528.15854. Epub 2019 Jul 17.
8
Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: systematic review and meta-analysis.阴道微生态失调与人类乳头瘤病毒和宫颈癌的风险:系统评价和荟萃分析。
Am J Obstet Gynecol. 2019 Jul;221(1):9-18.e8. doi: 10.1016/j.ajog.2018.12.011. Epub 2018 Dec 12.
9
The Vaginal Microbiota, Human Papillomavirus Infection, and Cervical Carcinogenesis: A Systematic Review in the Latina Population.阴道微生物群、人乳头瘤病毒感染与宫颈癌发生:拉丁裔人群的系统评价
J Epidemiol Glob Health. 2024 Jun;14(2):480-497. doi: 10.1007/s44197-024-00201-z. Epub 2024 Feb 26.
10
Changes to the cervicovaginal microbiota and cervical cytokine profile following surgery for cervical intraepithelial neoplasia.宫颈上皮内瘤变手术后宫颈阴道微生物群和宫颈细胞因子谱的变化。
Sci Rep. 2021 Jan 25;11(1):2156. doi: 10.1038/s41598-020-80176-6.

引用本文的文献

1
The Vaginal Microbiota, Human Papillomavirus, and Cervical Dysplasia-A Review.阴道微生物群、人乳头瘤病毒与宫颈发育异常——综述
Medicina (Kaunas). 2025 May 5;61(5):847. doi: 10.3390/medicina61050847.
2
The effects of metabolites from three vaginal bacteria on the Syndecan-1 of cervical epithelial cells.三种阴道细菌的代谢产物对宫颈上皮细胞Syndecan-1的影响。
Heliyon. 2024 Jun 22;10(12):e33426. doi: 10.1016/j.heliyon.2024.e33426. eCollection 2024 Jun 30.
3
Host and Microbiome Interplay Shapes the Vaginal Microenvironment.宿主与微生物组相互作用塑造阴道微环境。
Front Immunol. 2022 Jun 28;13:919728. doi: 10.3389/fimmu.2022.919728. eCollection 2022.

本文引用的文献

1
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews.PRISMA 2020 声明:系统评价报告的更新指南。
BMJ. 2021 Mar 29;372:n71. doi: 10.1136/bmj.n71.
2
Changes to the cervicovaginal microbiota and cervical cytokine profile following surgery for cervical intraepithelial neoplasia.宫颈上皮内瘤变手术后宫颈阴道微生物群和宫颈细胞因子谱的变化。
Sci Rep. 2021 Jan 25;11(1):2156. doi: 10.1038/s41598-020-80176-6.
3
Microbiome definition re-visited: old concepts and new challenges.微生物组定义再探讨:旧概念和新挑战。
Microbiome. 2020 Jun 30;8(1):103. doi: 10.1186/s40168-020-00875-0.
4
Effects on Vaginal Microbiota Restoration and Cervical Epithelialization in Positive HPV Patients Undergoing Vaginal Treatment with Carboxy-Methyl-Beta-Glucan.HPV 阳性患者阴道应用羧甲基-β-葡聚糖治疗对阴道微生物群恢复和宫颈上皮化的影响。
Biomed Res Int. 2020 Apr 27;2020:5476389. doi: 10.1155/2020/5476389. eCollection 2020.
5
The Role of the Cervicovaginal Microbiome on the Genesis and as a Biomarker of Premalignant Cervical Intraepithelial Neoplasia and Invasive Cervical Cancer.宫颈阴道微生物组在癌前宫颈上皮内瘤变和浸润性宫颈癌的发生中的作用及其作为生物标志物的作用。
Int J Mol Sci. 2019 Dec 28;21(1):222. doi: 10.3390/ijms21010222.
6
Cervical microbiota in women with cervical intra-epithelial neoplasia, prior to and after local excisional treatment, a Norwegian cohort study.挪威队列研究:宫颈上皮内瘤变女性在局部切除治疗前后的宫颈微生物群
BMC Womens Health. 2019 Feb 6;19(1):30. doi: 10.1186/s12905-019-0727-0.
7
Cervicovaginal microbiota, women's health, and reproductive outcomes.宫颈阴道微生物群、女性健康和生殖结局。
Fertil Steril. 2018 Aug;110(3):327-336. doi: 10.1016/j.fertnstert.2018.06.036.
8
Does the vaginal microbiota play a role in the development of cervical cancer?阴道微生物群在宫颈癌的发展中起作用吗?
Transl Res. 2017 Jan;179:168-182. doi: 10.1016/j.trsl.2016.07.004. Epub 2016 Jul 15.
9
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.系统评价与Meta分析方案的首选报告项目(PRISMA-P)2015声明。
Syst Rev. 2015 Jan 1;4(1):1. doi: 10.1186/2046-4053-4-1.
10
An international registry of systematic-review protocols.一个系统评价方案的国际注册库。
Lancet. 2011 Jan 8;377(9760):108-9. doi: 10.1016/S0140-6736(10)60903-8. Epub 2010 Jul 12.